Diaporlabanoids A–C, Immunosuppressive Dinorlabdane Diterpene Alkaloids with an Unprecedented Carbon Skeleton from Mangrove Endophytic Fungus Diaporthe phaseolorum H3-2
Organic Letters · 2025
DOI: 10.1021/acs.orglett.5c01572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, 2025. Verfasst von Ting Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Ecological Civilization, School of Chemistry and Chemical Engineering, Hainan University, Haikou 570228, China. Hauptthemen laut MEDLINE: Diterpenes, Alkaloids, Immunosuppressive Agents, Ascomycota. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Hainan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center of Ecological Civilization, School of Chemistry and Chemical Engineering, Hainan University, Haikou 570228, China.
ORCID-Profile: Jing Xu
Förderung
- Hainan University
- National Natural Science Foundation of China
Zitieren
APA
Feng, T., Deng, X., Xu, Z., & Xu, J. (2025). Diaporlabanoids A–C, Immunosuppressive Dinorlabdane Diterpene Alkaloids with an Unprecedented Carbon Skeleton from Mangrove Endophytic Fungus Diaporthe phaseolorum H3-2. Organic Letters. https://doi.org/10.1021/acs.orglett.5c01572
Vancouver
Feng T, Deng X, Xu Z, Xu J. Diaporlabanoids A–C, Immunosuppressive Dinorlabdane Diterpene Alkaloids with an Unprecedented Carbon Skeleton from Mangrove Endophytic Fungus Diaporthe phaseolorum H3-2. Organic Letters. 2025. doi:10.1021/acs.orglett.5c01572
BibTeX
@article{Feng2025,
author = {Feng, Ting and Deng, Xiaolin and Xu, Zhiyong and Xu, Jing},
title = {Diaporlabanoids A–C, Immunosuppressive Dinorlabdane Diterpene Alkaloids with an Unprecedented Carbon Skeleton from Mangrove Endophytic Fungus Diaporthe phaseolorum H3-2},
journal = {Organic Letters},
year = {2025},
doi = {10.1021/acs.orglett.5c01572}
}
EUVIMED